Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study-Reference-Cited by-同舟云学术

Clinical factors associated with abandonment of a rate-control or a rhythm-control strategy for the management of atrial fibrillation in the AFFIRM study

Published:2005-02 Issue:2 Volume:149 Page:304-308
ISSN:0002-8703
Container-title:American Heart Journal
language:en
Short-container-title:American Heart Journal

Author:

Curtis Anne B.,Seals A. Allen,Safford Robert E.,Slater William,Tullo Nicholas G.,Vidaillet Humberto,Wilber David J.,Slee April

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference8 articles.

1. A comparison of rate control and rhythm control in patients with atrial fibrillation;N. Engl. J. Med.,2002

2. Baseline characteristics of patients with atrial fibrillation: the AFFIRM Study;Am. Heart J.,2002

3. Serial antiarrhythmic drug treatment to maintain sinus rhythm after electrical cardioversion for chronic atrial fibrillation or atrial flutter;Crijns;Am. J. Cardiol.,1991

4. Amiodarone to prevent recurrence of atrial fibrillation;Roy;N. Engl. J. Med.,2000

5. Maintenance of sinus rhythm in patients with atrial fibrillation: an AFFIRM substudy of the first antiarrhythmic drug;J. Am. Coll. Cardiol.,2003

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Orally Inhaled Flecainide for Conversion of Atrial Fibrillation to Sinus Rhythm;JACC: Clinical Electrophysiology;2024-06

2. Pharmacologic Rate versus Rhythm Control for Atrial Fibrillation in Heart Failure Patients;Medicina;2022-05-30

3. Catheter ablation or medical therapy to delay progression of atrial fibrillation: the randomized controlled atrial fibrillation progression trial (ATTEST);EP Europace;2020-12-17

4. Functional status with rhythm versus rate control strategies for persistent atrial fibrillation;Polish Archives of Internal Medicine;2018-08-16

5. Catheter Ablation and Antiarrhythmic Drug Therapy as First- or Second-Line Therapy in the Management of Atrial Fibrillation;Circulation: Arrhythmia and Electrophysiology;2014-10